Dual-mode CRISPR/Cas12a-mediated alkaline phosphatase detection (CAD) biosensor
Abstract
, offering the potential to effectively differentiate pathological samples from normal physiological levels with an appropriate dilution factor for clinical samples. Our dual-mode biosensing strategy not only enables high-precision quantitative analysis in clinical settings but also facilitates rapid qualitative detection under resource-limited conditions, thus offering significant potential for early disease diagnosis and long-term therapeutic monitoring.
Fields of Study & Subjects
Advanced biosensing and bioanalysis techniques
Biosensors and Analytical Detection
CRISPR and Genetic Engineering
Publication details
- Journal / source
- Analytical Methods
- Volume
- 18
- Issue
- 6
- Pages
- 1239–1247
- Publication date
- 1 January 2026
- Language
- EN